Diametric Capital LP decreased its stake in shares of Centuri Holdings, Inc. (NYSE:CTRI - Free Report) by 50.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,067 shares of the company's stock after selling 15,505 shares during the period. Diametric Capital LP's holdings in Centuri were worth $291,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of CTRI. Charles Schwab Investment Management Inc. lifted its holdings in Centuri by 3.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 111,364 shares of the company's stock worth $1,799,000 after buying an additional 3,818 shares during the period. BNP Paribas Financial Markets lifted its stake in shares of Centuri by 39.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,827 shares of the company's stock valued at $110,000 after purchasing an additional 1,927 shares during the period. MetLife Investment Management LLC boosted its position in shares of Centuri by 129.1% during the third quarter. MetLife Investment Management LLC now owns 8,243 shares of the company's stock valued at $133,000 after purchasing an additional 4,645 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Centuri in the third quarter worth $211,000. Finally, Centiva Capital LP bought a new position in Centuri in the third quarter worth $162,000.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. Robert W. Baird reduced their target price on shares of Centuri from $23.00 to $22.00 and set an "outperform" rating on the stock in a research report on Thursday, February 27th. JPMorgan Chase & Co. upped their price objective on shares of Centuri from $17.00 to $19.00 and gave the stock an "underweight" rating in a report on Tuesday, January 28th. Two analysts have rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Centuri presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.00.
Get Our Latest Analysis on Centuri
Centuri Stock Down 2.7 %
Centuri stock traded down $0.44 during trading hours on Friday, hitting $15.81. The stock had a trading volume of 440,242 shares, compared to its average volume of 495,628. The stock's 50-day moving average price is $18.55 and its 200-day moving average price is $19.11. The stock has a market capitalization of $1.40 billion and a P/E ratio of -0.07. Centuri Holdings, Inc. has a 12-month low of $14.46 and a 12-month high of $28.65. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 1.70.
About Centuri
(
Free Report)
Centuri Holdings, Inc operates as a utility infrastructure services company in North America. It offers gas utility services, including maintenance, repair, installation, and replacement services for natural gas local distribution utility companies with focus on the modernization of infrastructure. The company also provides electric utility services comprising design, maintenance and repair, upgrade, and expansion services for transmission and distribution infrastructure.
See Also

Before you consider Centuri, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centuri wasn't on the list.
While Centuri currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.